ClinicalTrials.govpublic full text
Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients with Type 2 Diabetes
type2 diabetes, type 2 diabetes, diabetes mellitus, gabaa receptor, β-cell function, glycemic control, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010693
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.